AGP Executive Report
Last update: 9 hours agoCancer Medicines: Roche’s new partnership with China’s Hansoh Pharma could exceed US$15 billion and covers a portfolio of experimental cancer drugs. Hansoh retains development and sales rights in Macau and other listed Asian markets. Public Health: Macau’s Health Bureau reported six flu-like illness clusters, while authorities urged residents to take mosquito precautions during the Chong Yeung Festival. Macau also tightened screening after an unexplained pneumonia death in Russia. Cancer Research: University of Macau researchers identified a high-risk liver cancer subtype and a potential AI-guided precision treatment strategy. Care for Older Residents: Caritas has added two kitchens to its elderly meal network, while a local symposium examined end-of-life care and palliative services. Workplace Well-being: A Macau forum brought employers, health professionals and community representatives together to discuss making mental health a shared workplace responsibility.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Pharmaceutical Executive Daily: Hansoh Pharma Enters Collaboration and License Agreement with Roche for Broad Portfolio of ADCs]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/24990778-912932933-69ad66ff9a88b963b53a43ee2436f89da07d52ad-1280x720-100x56.jpeg)
![<![CDATA[Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche ]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29561996-950737670-acb9bd2e489dc2c0b4dbaf2e1ff766fc9d5ddff8-1280x720-200x113.png)
